Virology News and Research

Latest Virology News and Research

TSRI scientists show how to target weak spots of Marburg virus with future treatments

Marburg virus is Ebola's deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it.

27 Feb 2015

Researchers reveal how human immune system can fight against deadly Marburg virus

A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University and The Scripps Research Institute have identified mechanisms involved in antibody response to the deadly Marburg virus by studying the blood of a Marburg survivor.

27 Feb 2015

Predicting the development of type 1 diabetes is possible, shows TEDDY study

New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the body's own insulin cells.

26 Feb 2015

Study may give health workers vital new evidence in fight against Ebola

One year after the first Ebola cases started to surface in Guinea, the latest findings from a Cochrane review show new ways of hydrating patients in critical care environments across the world.

26 Feb 2015

Study reveals causes of community-acquired pneumonia in children

With the chill of winter comes a spike in community-acquired pneumonia (CAP), which spreads more easily as people retreat indoors and come into close contact. The lung infection triggers persistent coughing, chest pain, fever, and difficulty breathing, and is particularly hard on the very young and the very old. In fact, pneumonia is the leading cause of hospitalization among U.S. children, with estimated medical costs of $1 billion annually.

26 Feb 2015

Study points respiratory viruses as the most common cause of childhood pneumonia

Respiratory viruses, not bacterial infections, are the most commonly detected causes of community-acquired pneumonia in children, according to new research released Feb. 26 in the New England Journal of Medicine.

26 Feb 2015

Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

The Georgia Institute of Technology and Micron Biomedical have been awarded $2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. The patches will be studied to evaluate their potential role as part of the worldwide efforts to eradicate polio.

25 Feb 2015

Scientists detect new molecule that contributes to development of liver fibrosis

Liver fibrosis, which is the progressive formation of scar tissue in the liver, is a massive medical problem. An estimated ten percent of the population is affected by liver fibrosis or its corresponding later stage, liver cirrhosis. A variety of causes can lead to liver fibrosis, the most widely recognized ones being alcohol consumption and virus-induced chronic liver inflammation.

25 Feb 2015

Simple paper strip test can rapidly diagnose Ebola

When diagnosing a case of Ebola, time is of the essence. However, existing diagnostic tests take at least a day or two to yield results, preventing health care workers from quickly determining whether a patient needs immediate treatment and isolation.

25 Feb 2015

Study shows how financial incentives can influence some HIV-positive patients in clinical settings

A new study by the HIV Prevention Trials Network shows that some HIV-positive patients were motivated by financial incentives to take their HIV antiretroviral therapy (ART) medication regularly and maintain control of their HIV - enhancing their own health benefits and reducing the chance of passing the virus on to others.

25 Feb 2015

Medicago receives task order from HHS BARDA to manufacture anti-Ebola virus monoclonal antibodies

Medicago, a leading company in the development and production of plant-based vaccines and therapeutics, announced today that it has received a task order from the Biomedical Advanced Research and Development Authority at the U.S. Department of Health and Human Services for three anti-Ebola virus monoclonal antibodies (mAbs) with expected performance comparable to that of ZMapp, from Mapp Biopharmaceutical.

24 Feb 2015

‘Most’ cirrhotic HBV patients benefit from adding adefovir to lamivudine

Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function.

23 Feb 2015

Study: Airport screening for disease often misses infected travellers, but can be improved

Scientists have shown that airport screening for disease will often miss half or more of infected travellers, but can be improved by customizing to pathogens.

23 Feb 2015

New Duke-NUS-led study identifies super-potent antibody that can neutralize dengue virus

A new Duke-NUS-led study has identified a super-potent antibody which requires a minute amount to neutralize the dengue virus.

21 Feb 2015

International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

Approximately 12,000 women are diagnosed with cervical cancer each year in the United States and another 4,000 die annually from the disease. However, most cervical cancers are preventable through immunization against the human papillomavirus (HPV). A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease.

21 Feb 2015

Betaretrovirus may infect patients with primary biliary cirrhosis

In a new study published in Alimentary Pharmacology & Therapeutics, researchers at the University of Alberta's Faculty of Medicine & Dentistry have shown that a betaretrovirus which resembles a mouse mammary tumor virus infects patients with the rare liver disease, primary biliary cirrhosis (PBC).

20 Feb 2015

Virus that causes chicken pox and shingles linked to giant cell arteritis

A new study developed at the University of Colorado School of Medicine at the Anschutz Medical Campus links the virus that causes chicken pox and shingles to a condition that inflames blood vessels on the temples and scalp in the elderly, called giant cell arteritis.

20 Feb 2015

Global survey uncovers shocking lack of preparedness against rabies across Africa and Asia

The first global survey of rabies reporting systems, published this week, has uncovered a shocking lack of preparedness against this deadly disease across Africa and Asia. Accurate reporting of rabies cases to authorities is a critical first step in controlling rabies and preventing further outbreaks.

20 Feb 2015

Scientists develop promising new HIV vaccine agent

In a study that involved researchers from over a dozen institutions, the anti-HIV agent protected monkeys from every strain of HIV-1, HIV-2 and SIV (simian immunodeficiency virus) for at least 34 weeks.

19 Feb 2015

Adeptus Health's net revenue increases 108.0% to $70.1 million in fourth quarter 2014

Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., announced its results for the fourth quarter and full year ended December 31, 2014.

19 Feb 2015

Virology News and Research

Latest Virology News and Research

TSRI scientists show how to target weak spots of Marburg virus with future treatments

Researchers reveal how human immune system can fight against deadly Marburg virus

Predicting the development of type 1 diabetes is possible, shows TEDDY study

Study may give health workers vital new evidence in fight against Ebola

Study reveals causes of community-acquired pneumonia in children

Study points respiratory viruses as the most common cause of childhood pneumonia

Gates Foundation awards $2.5 million to support development of vaccine-filled microneedles

Scientists detect new molecule that contributes to development of liver fibrosis

Simple paper strip test can rapidly diagnose Ebola

Study shows how financial incentives can influence some HIV-positive patients in clinical settings

Medicago receives task order from HHS BARDA to manufacture anti-Ebola virus monoclonal antibodies

‘Most’ cirrhotic HBV patients benefit from adding adefovir to lamivudine

Study: Airport screening for disease often misses infected travellers, but can be improved

New Duke-NUS-led study identifies super-potent antibody that can neutralize dengue virus

International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

Betaretrovirus may infect patients with primary biliary cirrhosis

Virus that causes chicken pox and shingles linked to giant cell arteritis

Global survey uncovers shocking lack of preparedness against rabies across Africa and Asia

Scientists develop promising new HIV vaccine agent

Adeptus Health's net revenue increases 108.0% to $70.1 million in fourth quarter 2014

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production